5OF9
Crystal structure of human MORC2 (residues 1-603)
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID30B |
Synchrotron site | ESRF |
Beamline | ID30B |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2016-11-29 |
Detector | DECTRIS PILATUS3 6M |
Wavelength(s) | 0.972636 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 66.170, 127.930, 80.190 |
Unit cell angles | 90.00, 101.22, 90.00 |
Refinement procedure
Resolution | 64.906 - 1.807 |
R-factor | 0.1624 |
Rwork | 0.161 |
R-free | 0.18800 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5ix2 |
RMSD bond length | 0.012 |
RMSD bond angle | 1.108 |
Data reduction software | XDS (1.1.7) |
Data scaling software | Aimless (1.1.7) |
Phasing software | PHASER |
Refinement software | PHENIX ((1.12rc2_2821: ???)) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 78.658 | 78.658 | 1.838 |
High resolution limit [Å] | 1.807 | 4.905 | 1.807 |
Rmerge | 0.082 | 0.053 | 0.901 |
Rpim | 0.049 | 0.032 | 0.555 |
Number of reflections | 118149 | 5994 | 5948 |
<I/σ(I)> | 13.6 | 28.8 | 2.1 |
Completeness [%] | 98.9 | 98.5 | 98.3 |
Redundancy | 6.7 | 6.3 | 6.3 |
CC(1/2) | 0.998 | 0.996 | 0.684 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 291 | 0.1 M bicine/Trizma pH 8.5 9% PEG 4000 18% glycerol 0.02 M each of the following: 1,6-hexanediol; 1-butanol; RS-1,2 propanediol; 2-propanol; 1,4-butanediol; 1,3-propanediol Based on Morpheus crystal screen |